Paster Anne-Mari

10% owner at Lexeo Therapeutics, Inc. · on record since Nov 9, 2023
10% owner at Theseus Pharmaceuticals, Inc. · on record since Oct 6, 2021
10% owner at Precipio, Inc. · on record since Jun 27, 2018
Former 10% Owner at Kezar Life Sciences, Inc. · on record since Jun 25, 2018
10% owner at Kezar Life Sciences, Inc. · on record since Jun 20, 2018
10% owner at Replimune Group, Inc. · on record since Jul 25, 2018
10% owner at Morphic Holding, Inc. · on record since Jun 26, 2019
10% owner at IMMUNIC, INC. · on record since Apr 22, 2019
10% owner at KRONOS INC · on record since Oct 16, 2020
10% owner at Panacea Acquisition Corp. II · on record since Feb 12, 2021
Former 10% owner at Theseus Pharmaceuticals, Inc. · on record since Oct 14, 2021

Insider trading activity of Paster Anne-Mari

Transactions on record: 13; since Jul 1, 2019

Open-market buys: 3; $10M

Open-market sells: 0

Companies traded: 3; last filing Nov 9, 2023

Figures computed from official regulatory filings — .

Companies where Paster Anne-Mari has traded

Lexeo Therapeutics, Inc.5 tx · $5M · Nov 9, 2023
Theseus Pharmaceuticals, Inc.3 tx · $3M · Oct 14, 2021
Morphic Holding, Inc.5 tx · $2M · Jul 1, 2019

Track record of Paster Anne-Mari

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Paster Anne-Mari

Co-insiders of Paster Anne-Mari

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Lexeo Therapeutics, Inc.Listing on record	Nov 9, 2023	Other	287,213	—	n/a (No price was disclosed in the filing)		SEC
Lexeo Therapeutics, Inc.Listing on record	Nov 9, 2023	Buy	454,545	11.00 USD	$5M	conv 66ClusterFirst in 12mo	SEC
Lexeo Therapeutics, Inc.Listing on record	Nov 9, 2023	Other	1,415,865	—	n/a (No price was disclosed in the filing)		SEC
Lexeo Therapeutics, Inc.Listing on record	Nov 9, 2023	OtherD (derivative)	-14,999,999	—	n/a (No price was disclosed in the filing)		SEC
Lexeo Therapeutics, Inc.Listing on record	Nov 9, 2023	OtherD (derivative)	-2,615,533	—	n/a (No price was disclosed in the filing)		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Oct 14, 2021	Other	523,979	—	n/a (No price was disclosed in the filing)		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Oct 14, 2021	OtherD (derivative)	-693,152	—	n/a (No price was disclosed in the filing)		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Oct 14, 2021	Buy	187,500	16.00 USD	$3M	conv 61ClusterFirst in 12mo	SEC
Morphic Holding, Inc.Listing unverified	Jul 1, 2019	Buy	133,333	15.00 USD	$2M	conv 43ClusterFirst in 12mo	SEC
Morphic Holding, Inc.Listing unverified	Jul 1, 2019	OtherD (derivative)	-1,978,779	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Morphic Holding, Inc.Listing unverified	Jul 1, 2019	Other	1,978,779	—	n/a (No price was disclosed in the filing)		SEC
Morphic Holding, Inc.Listing unverified	Jul 1, 2019	Other	857,470	—	n/a (No price was disclosed in the filing)		SEC
Morphic Holding, Inc.Listing unverified	Jul 1, 2019	OtherD (derivative)	-857,470	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Lexeo Therapeutics, Inc.Listing on record	Nov 9, 2023	Other	287,213	—	n/a (No price was disclosed in the filing)		SEC
Lexeo Therapeutics, Inc.Listing on record	Nov 9, 2023	Buy	454,545	11.00 USD	$5M	conv 66ClusterFirst in 12mo	SEC
Lexeo Therapeutics, Inc.Listing on record	Nov 9, 2023	Other	1,415,865	—	n/a (No price was disclosed in the filing)		SEC
Lexeo Therapeutics, Inc.Listing on record	Nov 9, 2023	OtherD (derivative)	-14,999,999	—	n/a (No price was disclosed in the filing)		SEC
Lexeo Therapeutics, Inc.Listing on record	Nov 9, 2023	OtherD (derivative)	-2,615,533	—	n/a (No price was disclosed in the filing)		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Oct 14, 2021	Other	523,979	—	n/a (No price was disclosed in the filing)		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Oct 14, 2021	OtherD (derivative)	-693,152	—	n/a (No price was disclosed in the filing)		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Oct 14, 2021	Buy	187,500	16.00 USD	$3M	conv 61ClusterFirst in 12mo	SEC
Morphic Holding, Inc.Listing unverified	Jul 1, 2019	Buy	133,333	15.00 USD	$2M	conv 43ClusterFirst in 12mo	SEC
Morphic Holding, Inc.Listing unverified	Jul 1, 2019	OtherD (derivative)	-1,978,779	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Morphic Holding, Inc.Listing unverified	Jul 1, 2019	Other	1,978,779	—	n/a (No price was disclosed in the filing)		SEC
Morphic Holding, Inc.Listing unverified	Jul 1, 2019	Other	857,470	—	n/a (No price was disclosed in the filing)		SEC
Morphic Holding, Inc.Listing unverified	Jul 1, 2019	OtherD (derivative)	-857,470	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC